{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:23:34Z","timestamp":1790882614773,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2016R1A2A1A05005078"],"award-info":[{"award-number":["2016R1A2A1A05005078"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2015R1A2A2A01002524"],"award-info":[{"award-number":["2015R1A2A2A01002524"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Science"},{"name":"ICT"},{"name":"Future Planning (MISP)"},{"name":"Intelligent Synthetic Biology Center of the Global Frontier Project","award":["20110031961"],"award-info":[{"award-number":["20110031961"]}]},{"name":"Ministry of Agriculture, Food and Rural Affairs, Republic of Korea"},{"DOI":"10.13039\/501100003627","name":"Rural Development Administration","doi-asserted-by":"publisher","award":["PJ011066"],"award-info":[{"award-number":["PJ011066"]}],"id":[{"id":"10.13039\/501100003627","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Biotechnology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.copbio.2017.03.019","type":"journal-article","created":{"date-parts":[[2017,3,30]],"date-time":"2017-03-30T23:23:53Z","timestamp":1490916233000},"page":"33-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Biosynthetic pathways of aminoglycosides and their engineering"],"prefix":"10.1016","volume":"48","author":[{"given":"Je Won","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon Hee","family":"Ban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Jip","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun-Shin","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeo Joon","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.copbio.2017.03.019_bib0005","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1126\/science.100.2588.103.b","article-title":"Control of gram-negative bacteria in experimental animals by streptomycin","volume":"100","author":"Jones","year":"1944","journal-title":"Science"},{"key":"10.1016\/j.copbio.2017.03.019_bib0010","article-title":"Enabling techniques in the search for new antibiotics: combinatorial biosynthesis of sugar-containing antibiotics","author":"Park","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.copbio.2017.03.019_bib0015","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1021\/cr0404085","article-title":"2-Deoxystreptamine: central scaffold of aminoglycoside antibiotics","volume":"105","author":"Busscher","year":"2005","journal-title":"Chem Rev"},{"key":"10.1016\/j.copbio.2017.03.019_bib0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1039\/C2NP20092A","article-title":"2-Deoxystreptamine-containing aminoglycoside antibiotics: recent advances in the characterization and manipulation of their biosynthetic pathways","volume":"30","author":"Park","year":"2013","journal-title":"Nat Prod Rep"},{"key":"10.1016\/j.copbio.2017.03.019_bib0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/tcr.201500210","article-title":"Aminoglycoside antibiotics: new insights into the biosynthetic machinery of old drugs","volume":"16","author":"Kudo","year":"2016","journal-title":"Chem Rec"},{"key":"10.1016\/j.copbio.2017.03.019_bib0030","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1021\/cr0301088","article-title":"Molecular insights into aminoglycoside action and resistance","volume":"105","author":"Magnet","year":"2005","journal-title":"Chem Rev"},{"key":"10.1016\/j.copbio.2017.03.019_bib0035","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1021\/cb3005116","article-title":"Aminoglycoside antibiotics in the 21st century","volume":"8","author":"Becker","year":"2013","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.copbio.2017.03.019_bib0040","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nrmicro1265","article-title":"The bacterial ribosome as a target for antibiotics","volume":"3","author":"Poehlsgaard","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.copbio.2017.03.019_bib0045","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.clpt.6100012","article-title":"Aminoglycoside-induced translational read-through in disease: overcoming nonsense mutations by pharmacogenetic therapy","volume":"81","author":"Zingman","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.copbio.2017.03.019_bib0050","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/MCP.0b013e32833eebfd","article-title":"Aminoglycoside use in cystic fibrosis: therapeutic strategies and toxicity","volume":"16","author":"Prayle","year":"2010","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.copbio.2017.03.019_bib0055","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nchembio.596","article-title":"Discovery of selective bioactive small molecules by targeting an RNA dynamic ensemble","volume":"7","author":"Stelzer","year":"2011","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.copbio.2017.03.019_bib0060","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1021\/cb400498n","article-title":"Structure-guided discovery of a novel aminoglycoside conjugate targeting HIV-1 RNA viral genome","volume":"8","author":"Ennifar","year":"2013","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.copbio.2017.03.019_bib0065","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1021\/acs.joc.5b00248","article-title":"Structure-activity relationships for antibacterial to antifungal conversion of kanamycin to amphiphilic analogues","volume":"80","author":"Fosso","year":"2015","journal-title":"J Org Chem"},{"key":"10.1016\/j.copbio.2017.03.019_bib0070","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/med.20085","article-title":"Modifications of aminoglycoside antibiotics targeting RNA","volume":"27","author":"Zhou","year":"2007","journal-title":"Med Res Rev"},{"key":"10.1016\/j.copbio.2017.03.019_bib0075","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1517\/14656566.2013.806486","article-title":"Aminoglycoside therapy in infectious diseases","volume":"14","author":"Poulikakos","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.copbio.2017.03.019_bib0080","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.drup.2010.08.003","article-title":"Aminoglycoside modifying enzymes","volume":"13","author":"Ramirez","year":"2010","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.copbio.2017.03.019_bib0085","first-page":"462","article-title":"Combinatorial synthesis of aminoglycoside libraries","volume":"4","author":"Sucheck","year":"2001","journal-title":"Curr Opin Drug Discov Dev"},{"key":"10.1016\/j.copbio.2017.03.019_bib0090","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fcimb.2013.00022","article-title":"Prospects for circumventing aminoglycoside kinase mediated antibiotic resistance","volume":"3","author":"Shi","year":"2013","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.copbio.2017.03.019_bib0095","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.copbio.2011.12.016","article-title":"Synthetic biological approaches to natural product biosynthesis","volume":"23","author":"Winter","year":"2012","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.copbio.2017.03.019_bib0100","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nchembio.1893","article-title":"Reinvigorating natural product combinatorial biosynthesis with synthetic biology","volume":"11","author":"Kim","year":"2015","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.copbio.2017.03.019_bib0105","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.mib.2016.05.011","article-title":"Old dogs and new tricks in antimicrobial discovery","volume":"33","author":"Butler","year":"2016","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.copbio.2017.03.019_bib0110","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.copbio.2016.04.006","article-title":"Evolving medicinal chemistry strategies in antibiotic discovery","volume":"42","author":"Pawlowski","year":"2016","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.copbio.2017.03.019_bib0115","article-title":"History of antimicrobial drug discovery\u2014major classes and health impact","author":"Aminov","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.copbio.2017.03.019_bib0120","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.chembiol.2005.04.010","article-title":"Biosynthesis of the unique amino acid side chain of butirosin: possible protective-group chemistry in an acyl carrier protein-mediated pathway","volume":"12","author":"Li","year":"2005","journal-title":"Chem Biol"},{"key":"10.1016\/j.copbio.2017.03.019_bib0125","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.chembiol.2007.02.005","article-title":"Biosynthesis of butirosin: transfer and deprotection of the unique amino acid side chain","volume":"14","author":"Llewellyn","year":"2007","journal-title":"Chem Biol"},{"key":"10.1016\/j.copbio.2017.03.019_sbref0130","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1039\/b802248h","article-title":"Chemoenzymatic acylation of aminoglycoside antibiotics","volume":"32","author":"Llewellyn","year":"2008","journal-title":"Chem Commun (Camb)"},{"key":"10.1016\/j.copbio.2017.03.019_sbref0135","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nchembio.671","article-title":"Discovery of parallel pathways of kanamycin biosynthesis allows antibiotic manipulation","volume":"7","author":"Park","year":"2011","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.copbio.2017.03.019_bib0140","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/cbic.201402612","article-title":"Epimerization at C-3 in butirosin biosynthesis by an NAD(+)-dependent dehydrogenase BtrE and an NADPH-dependent reductase BtrF","volume":"16","author":"Takeishi","year":"2015","journal-title":"Chembiochem"},{"key":"10.1016\/j.copbio.2017.03.019_bib0145","doi-asserted-by":"crossref","first-page":"13909","DOI":"10.1021\/ja507759f","article-title":"Characterization of a radical S-adenosyl-l-methionine epimerase, NeoN, in the last step of neomycin B biosynthesis","volume":"136","author":"Kudo","year":"2014","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.copbio.2017.03.019_bib0150","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1002\/anie.201108122","article-title":"The last step of kanamycin biosynthesis: unique deamination reaction catalyzed by the alpha-ketoglutarate-dependent nonheme iron dioxygenase KanJ and the NADPH-dependent reductase KanK","volume":"51","author":"Sucipto","year":"2012","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.copbio.2017.03.019_bib0155","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00253-010-2908-5","article-title":"Construction of kanamycin B overproducing strain by genetic engineering of Streptomyces tenebrarius","volume":"89","author":"Ni","year":"2011","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.copbio.2017.03.019_bib0160","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1002\/anie.201510635","article-title":"C3\u2032-deoxygenation of paromamine catalyzed by a radical S-adenosylmethionine enzyme: characterization of the enzyme AprD4 and its reductase partner AprD3","volume":"55","author":"Kim","year":"2016","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.copbio.2017.03.019_bib0165","doi-asserted-by":"crossref","first-page":"6427","DOI":"10.1021\/jacs.6b02221","article-title":"Characterization of a C3 deoxygenation pathway reveals a key branch point in aminoglycoside biosynthesis","volume":"138","author":"Lv","year":"2016","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.copbio.2017.03.019_bib0170","article-title":"Substrate specificity of radical S-adenosyl-l-methionine dehydratase AprD4 and its partner reductase AprD3 in the C3\u2032-deoxygenation of aminoglycoside antibiotics","author":"Kudo","year":"2016","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.copbio.2017.03.019_bib0175","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/07388550802262197","article-title":"Microbial biosynthesis and applications of gentamicin: a critical appraisal","volume":"28","author":"Kumar","year":"2008","journal-title":"Crit Rev Biotechnol"},{"key":"10.1016\/j.copbio.2017.03.019_bib0180","doi-asserted-by":"crossref","first-page":"8399","DOI":"10.1073\/pnas.0803164105","article-title":"Genetic dissection of the biosynthetic route to gentamicin A2 by heterologous expression of its minimal gene set","volume":"105","author":"Park","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.copbio.2017.03.019_sbref0185","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.chembiol.2014.03.005","article-title":"Specificity and promiscuity at the branch point in gentamicin biosynthesis","volume":"21","author":"Guo","year":"2014","journal-title":"Chem Biol"},{"key":"10.1016\/j.copbio.2017.03.019_bib0190","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.chembiol.2014.12.012","article-title":"Delineating the biosynthesis of gentamicin X2, the common precursor of the gentamicin C antibiotic complex","volume":"22","author":"Huang","year":"2015","journal-title":"Chem Biol"},{"key":"10.1016\/j.copbio.2017.03.019_sbref0195","doi-asserted-by":"crossref","first-page":"8093","DOI":"10.1021\/ja312641f","article-title":"GenK-catalyzed C-6\u2032 methylation in the biosynthesis of gentamicin: isolation and characterization of a cobalamin-dependent radical SAM enzyme","volume":"135","author":"Kim","year":"2013","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.copbio.2017.03.019_bib0200","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/cbic.201500258","article-title":"Biosynthesis of epimers C2 and C2a in the gentamicin C complex","volume":"16","author":"Gu","year":"2015","journal-title":"Chembiochem"},{"key":"10.1016\/j.copbio.2017.03.019_bib0205","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.bmcl.2012.12.064","article-title":"Characterization of a key aminoglycoside phosphotransferase in gentamicin biosynthesis","volume":"23","author":"Shao","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.copbio.2017.03.019_bib0210","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ja.2008.111","article-title":"Biosynthesis of 3\u2032-deoxy-carbamoylkanamycinC in a Streptomyces tenebrarius mutant strain by tacB gene disruption","volume":"61","author":"Yu","year":"2008","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.copbio.2017.03.019_bib0215","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.micres.2012.12.006","article-title":"Construction of a gentamicin C1a-overproducing strain of Micromonospora purpurea by inactivation of the gacD gene","volume":"168","author":"Li","year":"2013","journal-title":"Microbiol Res"},{"key":"10.1016\/j.copbio.2017.03.019_sbref0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12934-015-0402-6","article-title":"Assembly of a novel biosynthetic pathway for gentamicin B production in Micromonospora echinospora","volume":"15","author":"Ni","year":"2016","journal-title":"Microb Cell Fact"},{"key":"10.1016\/j.copbio.2017.03.019_sbref0225","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.mib.2010.09.004","article-title":"Combating evolution with intelligent design: the neoglycoside ACHN-490","volume":"13","author":"Armstrong","year":"2010","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.copbio.2017.03.019_bib0230","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.1128\/AAC.00869-16","article-title":"Association between the presence of aminoglycoside-modifying enzymes and in vitro activity of gentamicin, tobramycin, amikacin, and plazomicin against Klebsiella pneumoniae carbapenemase- and extended-spectrum-beta-lactamase-producing Enterobacter species","volume":"60","author":"Haidar","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.copbio.2017.03.019_bib0235","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1586\/eri.12.25","article-title":"Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin","volume":"10","author":"Zhanel","year":"2012","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.copbio.2017.03.019_bib0240","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1039\/C5MD00344J","article-title":"Mechanisms of resistance to aminoglycoside antibiotics: overview and perspectives","volume":"7","author":"Garneau-Tsodikova","year":"2016","journal-title":"Medchemcomm"},{"key":"10.1016\/j.copbio.2017.03.019_sbref0245","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/nm.3458","article-title":"Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug efflux","volume":"20","author":"Lee","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.copbio.2017.03.019_bib0250","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.tim.2014.02.008","article-title":"Spectinamides: a challenge, a proof, and a suggestion","volume":"22","author":"Viveiros","year":"2014","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.copbio.2017.03.019_sbref0255","doi-asserted-by":"crossref","first-page":"8601","DOI":"10.1093\/nar\/gkv821","article-title":"Structural basis for selective targeting of leishmanial ribosomes: aminoglycoside derivatives as promising therapeutics","volume":"43","author":"Shalev","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.copbio.2017.03.019_sbref0260","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/cbic.200900584","article-title":"Exploring the substrate promiscuity of drug-modifying enzymes for the chemoenzymatic generation of N-acylated aminoglycosides","volume":"11","author":"Green","year":"2010","journal-title":"Chembiochem"},{"key":"10.1016\/j.copbio.2017.03.019_bib0265","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10529-008-9887-y","article-title":"Molecular cloning and sequence analysis of the sisomicin biosynthetic gene cluster from Micromonospora inyoensis","volume":"31","author":"Hong","year":"2009","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.copbio.2017.03.019_bib0270","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.copbio.2016.07.007","article-title":"Protein engineering approaches to chemical biotechnology","volume":"42","author":"Chen","year":"2016","journal-title":"Curr Opin Biotechnol"}],"container-title":["Current Opinion in Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958166917300022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958166917300022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T08:58:01Z","timestamp":1760691481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0958166917300022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":54,"alternative-id":["S0958166917300022"],"URL":"https:\/\/doi.org\/10.1016\/j.copbio.2017.03.019","relation":{},"ISSN":["0958-1669"],"issn-type":[{"value":"0958-1669","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biosynthetic pathways of aminoglycosides and their engineering","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.copbio.2017.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}